Biotech

GSK and Theravance Announce Outcome of US FDA Advisory Committee on BREO(R) ELLIPTA(R) in Asthma

LONDON, UNITED KINGDOM and SOUTH SAN FRANCISCO, CA: ...

Flamel Technologies Announces Fourth Quarter and Full Year Results of Fiscal Year 2014

LYON, FRANCE: Bloxiverz(TM) Increases Market Share in the Neostigmine Market; Product Revenue Guidance for 2015 of $170-$185 Million Reaffirmed; Conference Call With Management to Take Place at 10:00 am ET on March ...

ProMetic Successfully Completes Its PBI-4050 Phase Ib in Patients With Chronic Kidney Disease ("CKD")

LAVAL, QUEBEC: - No serious adverse events reported in CKD patients - PBI-4050 clinical programs to expand to novel indications in the USA and EU. - Enrolment of patients in PBI-4050 metabolic syndrome and type 2 di ...

Arch Biopartners Identifies Candidate Drug to Treat Psuedomonas Respiratory Infections

TORONTO, ONTARIO: ...

Spotlight Innovation Enters Into Purchase Agreement With Memcine Pharmaceuticals

WEST DES MOINES, IA: Memcine Pharmaceuticals' Immunoplex Vaccine Platform Technology Has Broad Applicability in Both Infectious Diseases and Oncology Immunotherapy ...

Regen Receives Green Light From FDA to Proceed With GLP Safety Study in Support of Its HemaXellerate Investigational New Drug Application

SAN DIEGO, CA: Company Believes GLP Safety Study Is the Last Hurdle for HemaXellerate IND ...

Boston Therapeutics and Advance Pharmaceutical Expand sugardown(R) Licensing Agreement to Japan; Increases Number of Asian Countries to 16

MANCHESTER, NH: APC Reiterates Commitment to Collaborate on Funding Clinical Trials ...

Cellceutix Advancing Treatment for Hidradenitis Suppurativa, Pre-IND Meeting Request to Food and Drug Administration

BEVERLY, MA: ...

Cleveland BioLabs Announces Completion of Dosing in Phase 1 Study of CBLB612 in Russian Federation

BUFFALO, NY: ...

Immunovaccine Announces Intent to Trade on OTCQX Marketplace in United States

HALIFAX, NOVA SCOTIA: Retains PCG Advisory to Build Wall Street Awareness ...